Delivery Order SPE2DB22D2006-SPE2DB25FW0GA
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,354.67 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (500-count supply) on July 14, 2025, with an ultimate completion date of July 15, 2025. This contract was awarded on a non-competitive, firm fixed-price basis under a delivery order structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this award represents a routine fulfillment...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in quantities of 100 units under a firm fixed-price contract. The award, valued at $2,591.90, was competitively awarded without set-aside designation and reflects a completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a competitive delivery order valued at $2,735.75 for Cetirizine HCL 10 mg tablets (100-count) by the Defense Logistics Agency Medical Supply Chain. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and carries firm fixed pricing with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,770.43 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count units) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cetirizine HCL 10 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $2,119.84, represents a non-competitive set-aside award and carries a completion deadline of August 22, 2025. The pharmaceutical products will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $8,787 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award from the agency's Medical Supply Chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.65 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count packages) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and represents a continuation of the contractor's role as a critical pharmaceutical supplier to federal healthcare systems. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $7,861.18. This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,405.38 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in unit dose packaging of 100 count on September 12, 2025. This competitively awarded, firm fixed price contract requires performance completion by September 15, 2025, with fulfillment originating from AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW0GADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets (500-count) with a contract ceiling value of $1,396.35. This competitively awarded, firm fixed-price delivery order was executed on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its comprehensive IDC with the DLA to fulfill federal medical procurement needs across military and veteran healthcare systems. The company's contract portfolio demonstrates extensive capability in supplying pharmaceutical products and medical supplies across multiple therapeutic domains through competitive, firm fixed-price delivery orders. This particular award for Cetirizine HCL tablets exemplifies AmerisourceBergen's role as a critical vendor within the DLA's Medical Supply Chain, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/24/25 |